HBW Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Ombrelle

This article was originally published in The Rose Sheet

Executive Summary

Two mil. samples of the avobenzone sunscreen will be distributed to dermatologists this spring by Cosmair division Galderma, which markets a number of Rx dermatological drugs and will detail Ombrelle in the U.S. The sampling strategy has worked well for the sunscreen in Canada where Ombrelle has been marketed by former owner DermTec for about five years and is the second largest-selling sunscreen, according to Cosmair. Consumer marketing for Ombrelle, including print ads, which are "under consideration," will be handled by Maybelline. In addition, Maybelline and the American Academy of Dermatology will sponsor a sun awareness program with Ombrelle sampling during the 1998 Ladies Professional Golf Association Tournaments. Galderma introduced Ombrelle SPF 15 at AAD's annual meeting in early March ("The Rose Sheet" March 9, p. 7). An SPF 30 lotion will debut in May with an SRP of $11 for a 4 oz. bottle and $14 for an 8 oz. bottle. The SPF 15 line costs $10 for a 4 oz. lotion or spray and $13 for an 8 oz. lotion...
Advertisement
Advertisement
UsernamePublicRestriction

Register

RS005245

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel